Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Hammel

Showing results (111-120 of 241) with videos related to

Pageof 25
Sort By:
European Radiology|June 5, 2014
CT and MR imaging of multilocular acinar cell cystadenoma: comparison with branch duct intraductal papillary mucinous neoplasia (IPMNs)Christophe Delavaud, Gaspard d'Assignies, Jérome Cros, et al.
Expert Review of Anticancer Therapy|September 16, 2020
PARP inhibition in treatment of pancreatic cancerPascal Hammel, Chen Zhang, Julia Matile, et al.
Neuroendocrinology|August 14, 2017
Digestive System Mixed Neuroendocrine-Non-Neuroendocrine NeoplasmsLouis de Mestier, Jérôme Cros, Cindy Neuzillet, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 6, 2021
Efficacy and tolerance of gemcitabine and nab-paclitaxel in elderly patients with advanced pancreatic ductal adenocarcinomaFlore Pignon, Anthony Turpin, Olivia Hentic, et al.
Clinics and Research in Hepatology and Gastroenterology|October 15, 2020
Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinomaPaul McLellan, Julie Henriques, Feryel Ksontini, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2021
Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic CarcinomaAntoine Schernberg, Dewi Vernerey, David Goldstein, et al.
Pancreas|June 22, 2005
Endocrine tumor and intraductal papillary mucinous neoplasm of the pancreas: a fortuitous association?Frédéric Marrache, Dominique Cazals-Hatem, Reza Kianmanesh, et al.
European Journal of Gastroenterology & Hepatology|March 14, 2012
Recurrence after surgical resection of gastrinoma: who, when, where and why?Frédérique Maire, Alain Sauvanet, Anne Couvelard, et al.
World Journal of Gastroenterology|September 13, 2012
FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-saltsCindy Neuzillet, Olivia Hentic, Benoît Rousseau, et al.
Therapeutic Advances in Medical Oncology|July 23, 2020
Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitorsPascal Hammel, Carole Vitellius, Émeric Boisteau, et al.
Pageof 25

Showing results (111-120 of 241) with videos related to

Sort By:
Pageof 25
European Radiology|June 5, 2014
CT and MR imaging of multilocular acinar cell cystadenoma: comparison with branch duct intraductal papillary mucinous neoplasia (IPMNs)Christophe Delavaud, Gaspard d'Assignies, Jérome Cros, et al.
Expert Review of Anticancer Therapy|September 16, 2020
PARP inhibition in treatment of pancreatic cancerPascal Hammel, Chen Zhang, Julia Matile, et al.
Neuroendocrinology|August 14, 2017
Digestive System Mixed Neuroendocrine-Non-Neuroendocrine NeoplasmsLouis de Mestier, Jérôme Cros, Cindy Neuzillet, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 6, 2021
Efficacy and tolerance of gemcitabine and nab-paclitaxel in elderly patients with advanced pancreatic ductal adenocarcinomaFlore Pignon, Anthony Turpin, Olivia Hentic, et al.
Clinics and Research in Hepatology and Gastroenterology|October 15, 2020
Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinomaPaul McLellan, Julie Henriques, Feryel Ksontini, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2021
Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic CarcinomaAntoine Schernberg, Dewi Vernerey, David Goldstein, et al.
Pancreas|June 22, 2005
Endocrine tumor and intraductal papillary mucinous neoplasm of the pancreas: a fortuitous association?Frédéric Marrache, Dominique Cazals-Hatem, Reza Kianmanesh, et al.
European Journal of Gastroenterology & Hepatology|March 14, 2012
Recurrence after surgical resection of gastrinoma: who, when, where and why?Frédérique Maire, Alain Sauvanet, Anne Couvelard, et al.
World Journal of Gastroenterology|September 13, 2012
FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-saltsCindy Neuzillet, Olivia Hentic, Benoît Rousseau, et al.
Therapeutic Advances in Medical Oncology|July 23, 2020
Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitorsPascal Hammel, Carole Vitellius, Émeric Boisteau, et al.
Pageof 25